World's Best Scientists 2026 revealed!
James S. Wilmott

James S. Wilmott

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
16353
World Ranking
12352
National Ranking
344

Overview

James S. Wilmott is a researcher affiliated with the University of Sydney in Australia, with a focus on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their research primarily encompasses oncology, immunology, molecular biology, cancer research, and biomedical engineering. The main topics of their work include cancer immunotherapy and biomarkers, immunotherapy and immune responses, cutaneous melanoma detection and management, CAR-T cell therapy research, melanoma and MAPK pathways, cancer genomics and diagnostics, and nanoplatforms for cancer theranostics.

They have authored numerous papers in prominent venues, contributing significantly to the scientific community. Some of their recent publications include:

  • Transcriptional downregulation of MHC class I and melanoma de-differentiation in resistance to PD-1 inhibition, 2020, Nature Communications
  • Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome, 2022, Nature Medicine
  • Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma, 2021, Nature Cancer
  • Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity, 2020, Nature Communications
  • CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells, 2020, Immunity

Frequent co-authors associated with their research include:

  • Richard A. Scolyer
  • Georgina V. Long
  • Alexander M. Menzies
  • Inês Pires da Silva
  • John F. Thompson

They regularly publish in journals such as Cancer Research, Pathology, bioRxiv (Cold Spring Harbor Laboratory), Clinical Cancer Research, and Nature Communications. These venues reflect the scope and impact of their investigations in cancer biology and therapy.

Best Publications

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Whole-genome landscapes of major melanoma subtypes

    Nicholas K. Hayward;Nicholas K. Hayward;James S. Wilmott;Nicola Waddell;Nicola Waddell;Peter A. Johansson

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.

    André Kahles;Kjong-Van Lehmann;Nora C Toussaint;Matthias Hüser

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

    Tuba N. Gide;Camelia Quek;Alexander M. Menzies;Annie T. Tasker

  • Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

    Imran G House;Imran G House;Peter Savas;Peter Savas;Junyun Lai;Junyun Lai;Amanda X. Y. Chen;Amanda X. Y. Chen

  • Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

    James Samuel Wilmott;Georgina V. Long;Julie R. Howle;Julie R. Howle;Lauren E. Haydu

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.

    Jason Madore;Ricardo E. Vilain;Ricardo E. Vilain;Alexander M. Menzies;Hojabr Kakavand

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

    Jarem Edwards;James S. Wilmott;Jason Madore;Tuba Nur Gide

  • Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma.

    Tuba N. Gide;James S. Wilmott;Richard A. Scolyer;Richard A. Scolyer;Georgina V. Long

  • UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas

    Stephen Q. Wong;Kelly Waldeck;Ismael A. Vergara;Jan Schröder;Jan Schröder;Jan Schröder

  • Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

    Georgina V. Long;James S. Wilmott;David Capper;David Capper;Matthias Preusser;Matthias Preusser

Frequent Co-Authors

Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Georgina V. Long
Georgina V. Long University of Sydney
John F. Thompson
John F. Thompson University of Sydney
Alexander M. Menzies
Alexander M. Menzies University of Sydney
Richard F. Kefford
Richard F. Kefford Macquarie University
Graham J. Mann
Graham J. Mann Australian National University
Nicholas K. Hayward
Nicholas K. Hayward QIMR Berghofer Medical Research Institute
Peter Hersey
Peter Hersey University of Sydney
Helen Rizos
Helen Rizos Macquarie University
Matteo S. Carlino
Matteo S. Carlino University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA can open doors to numerous career opportunities and further education. Many students explore specialized pathways, such as pursuing an affordable online MBA healthcare management degree. This can be a smart move if you are interested in leadership or administrative roles within the healthcare sector.

For those drawn to the technical and data-driven side of healthcare, consider the growing field of medical coding and billing. Understanding the differences between medical coding certification options, such as CPC and CCS, is essential, as each has unique advantages for career growth.

Entry into this field is accessible with the right certification, and medical coding jobs salary data shows competitive pay, especially for experienced professionals. If you are weighing this as a potential career, make sure to review the medical billing and coding outlook to learn about the benefits and challenges of the profession.

With online programs and flexible certification options, you can tailor your pathway in science and healthcare to your interests and future goals.

Best Scientists Citing James S. Wilmott

Trending Scientists

Recently Published Articles